APA (7th ed.) Citation

Collins, P. W., Quon, D. V. K., Makris, M., Chowdary, P., Kempton, C. L., Apte, S. J., . . . Gomperts, E. D. (2018). Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients. Haemophilia : the official journal of the World Federation of Hemophilia, 24(1), 104-112. https://doi.org/10.1111/hae.13324

Chicago Style (17th ed.) Citation

Collins, P. W., et al. "Pharmacokinetics, Safety and Efficacy of a Recombinant Factor IX Product, Trenonacog Alfa in Previously Treated Haemophilia B Patients." Haemophilia : The Official Journal of the World Federation of Hemophilia 24, no. 1 (2018): 104-112. https://doi.org/10.1111/hae.13324.

MLA (9th ed.) Citation

Collins, P. W., et al. "Pharmacokinetics, Safety and Efficacy of a Recombinant Factor IX Product, Trenonacog Alfa in Previously Treated Haemophilia B Patients." Haemophilia : The Official Journal of the World Federation of Hemophilia, vol. 24, no. 1, 2018, pp. 104-112, https://doi.org/10.1111/hae.13324.